US FDA Still Reviewing Liquidia ' s Inhaled Blood Pressure Drug US FDA Still Reviewing Liquidia ' s Inhaled Blood Pressure Drug

The U.S. Food and Drug Administration is still reviewing Liquidia ' s drug to treat a progressive blood vessel disorder related to a lung condition, the company said on...Reuters Health Information
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Pulmonary Medicine Source Type: news